マヤステニア・グラヴィスにおけるアセチルコリン合成と水解の動態学
Science (New York, N.Y.)
|August 13, 1971
まとめ
ミアステニア・グレイビス症の患者は,筋肉組織におけるコリン-O-アセチルトランスファーゼ (CAT) 活性が低下している. このCAT酵素機能の低下は,筋肉内の抑制物質に起因する可能性があります.
科学分野:
- バイオケミストリー バイオケミストリー
- 神経科学は神経科学である.
- 酵素学 酵素学とは
背景:
- ミアステニア・グレイビス (MG) は,筋肉の機能に影響する神経筋肉疾患です.
- コリン-O-アセチルトランスフェラーゼ (CAT) とアセチルコレネステラゼは,アセチルコレンの代謝における重要な酵素である.
- MGにおける酵素動態を理解することは,疾患のメカニズムにとって極めて重要です.
研究 の 目的:
- CATとアセチルコリネステラゼの運動特性を正常な被験者および筋縮症の被験者において調査する.
- 血清,皮膚線維芽細胞,筋肉組織における酵素活性を比較する.
- ミアステニア・グラヴィスに寄与する酵素機能の潜在的な変化を特定する.
主な方法:
- 動力学的研究は,血清,培養された皮膚線維芽細胞,および生検されたサルトリオス筋肉で実施されました.
- 酵素活性は,タンパク質の1ミリグラムあたりで測定されました.
- サブストラット濃度曲線を分析して,CATのV (max) を決定した.
主要な成果:
- タンパク質の1ミリグラムあたりのCAT活動の有意な減少は,正常な筋肉と比較して,筋骨筋筋に観察されました.
- ミアステニックと正常な筋肉の同質体間のアセチルコリネステラゼ活性における有意な違いは見つかりませんでした.
- ミアステニウム筋のCATに対するV (max) の低下は,触媒効率の低下を示唆する.
結論:
- ミアステニクス筋はコレリン-O-アセチルトランスフェラーゼの活性が低下している.
- この発見は,CAT基板結合またはミアステニウム筋肉の機能に影響を与える阻害剤の存在を示唆しています.
- これらの酵素変異は,マイアステニア・グラビスの病理生理学に役割を果たす可能性があります.
さらに関連する動画
12:18The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
Published on: December 26, 2014
10:45Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions
Published on: May 5, 2018
関連する概念動画
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:23Cholinergic Neurons: Neurotransmission
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...